Novel Contact Force-Sensing Pulsed Field Ablation Catheter Shows Promise in Paroxysmal AF Treatment
• First-in-human data demonstrates 100% acute procedural success with Omnypulse, a novel contact force-sensing pulsed field ablation catheter for paroxysmal atrial fibrillation treatment.
• The catheter showed promising durability with 84.5% of pulmonary veins remaining isolated at 3-month follow-up, with only four non-device-related adverse events reported.
• Comparable technology from Kardium (Globe) demonstrated 78% freedom from treatment failure at 12 months with 95% pulmonary vein isolation durability, suggesting significant advancements in AF ablation technology.
© Copyright 2025. All Rights Reserved by MedPath